| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total net revenues | $555K+337.0% | $127K-0.8% | $128K |
| Cost of goods sold | $7.2M+31.7% | $5.4M-6.8% | $5.8M |
| Gross Margin | $11.6M+33.3% | $8.7M+3.8% | $8.4M |
| Research and development | $1.3M+47.8% | $906K+3.8% | $873K |
| Depreciation and amortization | $140K+3.7% | $135K-36.9% | $214K |
| Selling, general and administrative | $9.0M+17.2% | $7.7M-13.9% | $8.9M |
| Total operating expenses | $10.5M+20.2% | $8.7M-12.8% | $10.0M |
| Operating income | $1.1M+19000.0% | $6K+100.4% | -$1.6M |
| Interest expense | -$1K+0.0% | -$1K+50.0% | -$2K |
| Interest income | $139K+47.9% | $94K+46.9% | $64K |
| Other expense net | -$78K-680.0% | -$10K+77.3% | -$44K |
| Total other income | $60K-27.7% | $83K+361.1% | $18K |
| Income before income taxes | $1.2M+1255.1% | $89K+105.7% | -$1.6M |
| Income tax expense | -$12K+20.0% | -$15K | — |
| Net income | $1.2M+1513.5% | $74K | — |
| Net income per common share, basic | $110.00+1000.0% | $10.00+106.7% | -$150.00 |
| Net income per common share, diluted | $110.00+1000.0% | $10.00+106.7% | -$150.00 |
| Weighted average common shares outstanding, basic | 10.61B+0.8% | 10.53B+1.3% | 10.39B |
| Weighted average common shares outstanding, diluted | 10.97B+3.5% | 10.60B+2.1% | 10.39B |
| Product [Member] | |||
| Royalty and Other Revenues [Member] | |||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.